Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jonathan Tunnicliffe Insider Profile
4 Followers
Jonathan Tunnicliffe, Director, Ten Percent Owner at Revance Therapeutics, holds 3.10M shares in Revance Therapeutics (Ticker: RVNC).
Jonathan Tunnicliffe has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jonathan Tunnicliffe's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Jonathan Tunnicliffe holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jonathan Tunnicliffe
Jonathan Tunnicliffe's Trading History
List of latest transactions for each holding click on a transaction to see Jonathan Tunnicliffe's performance on stock
You May Also Like
Jonathan Tunnicliffe insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Tunnicliffe?
The percentage of profitable transactions made by Jonathan Tunnicliffe is ―.
What is the average return per transaction made by Jonathan Tunnicliffe?
The average return per transaction made by Jonathan Tunnicliffe is ―.
What stocks does Jonathan Tunnicliffe hold?
Jonathan Tunnicliffe holds: RVNC stocks.
What was Jonathan Tunnicliffe’s latest transaction?
Jonathan Tunnicliffe latest transaction was an Uninformative Buy of ―.
What was Jonathan Tunnicliffe's most profitable transaction?
Jonathan Tunnicliffe’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jonathan Tunnicliffe's role in Revance Therapeutics?
Jonathan Tunnicliffe's role in Revance Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.